- Home
- LVWR vs ATXS Comparison
LVWR vs ATXS Comparison
Compare LVWR & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVWR
- ATXS
- Stock Information
- Founded
- LVWR 2022
- ATXS 2008
- Country
- LVWR United States
- ATXS United States
- Employees
- LVWR N/A
- ATXS N/A
- Industry
- LVWR
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- LVWR
- ATXS Health Care
- Exchange
- LVWR Nasdaq
- ATXS Nasdaq
- Market Cap
- LVWR N/A
- ATXS 401.2M
- IPO Year
- LVWR N/A
- ATXS 2015
- Fundamental
- Price
- LVWR $2.13
- ATXS $5.70
- Analyst Decision
- LVWR Hold
- ATXS Strong Buy
- Analyst Count
- LVWR 1
- ATXS 5
- Target Price
- LVWR $7.25
- ATXS $26.60
- AVG Volume (30 Days)
- LVWR 28.3K
- ATXS 289.1K
- Earning Date
- LVWR 04-24-2025
- ATXS 03-11-2025
- Dividend Yield
- LVWR N/A
- ATXS N/A
- EPS Growth
- LVWR N/A
- ATXS N/A
- EPS
- LVWR N/A
- ATXS N/A
- Revenue
- LVWR $26,633,000.00
- ATXS N/A
- Revenue This Year
- LVWR $249.13
- ATXS N/A
- Revenue Next Year
- LVWR $98.53
- ATXS N/A
- P/E Ratio
- LVWR N/A
- ATXS N/A
- Revenue Growth
- LVWR N/A
- ATXS N/A
- 52 Week Low
- LVWR $1.90
- ATXS $5.68
- 52 Week High
- LVWR $9.00
- ATXS $14.04
- Technical
- Relative Strength Index (RSI)
- LVWR 44.11
- ATXS 33.36
- Support Level
- LVWR $1.95
- ATXS $5.89
- Resistance Level
- LVWR $2.11
- ATXS $6.52
- Average True Range (ATR)
- LVWR 0.15
- ATXS 0.43
- MACD
- LVWR 0.05
- ATXS -0.02
- Stochastic Oscillator
- LVWR 45.45
- ATXS 1.24
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.